Cargando…
A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy
Macular corneal dystrophy (MCD) is an autosomal recessive disease featured by bilateral progressive stromal clouding and loss of vision, consequently necessitating corneal transplantation. Variants in CHST6 gene have been recognized as the most critical genetic components in MCD. Although many CHST6...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382428/ https://www.ncbi.nlm.nih.gov/pubmed/30716718 http://dx.doi.org/10.18632/aging.101807 |
_version_ | 1783396670114889728 |
---|---|
author | Zhang, Jing Wu, Dan Li, Yue Fan, Yidan Dai, Yiqin Xu, Jianjiang |
author_facet | Zhang, Jing Wu, Dan Li, Yue Fan, Yidan Dai, Yiqin Xu, Jianjiang |
author_sort | Zhang, Jing |
collection | PubMed |
description | Macular corneal dystrophy (MCD) is an autosomal recessive disease featured by bilateral progressive stromal clouding and loss of vision, consequently necessitating corneal transplantation. Variants in CHST6 gene have been recognized as the most critical genetic components in MCD. Although many CHST6 variants have been described until now, the detailed mechanisms underlying MCD are still far from understood. In this study, we integrated all the reported CHST6 variants described in 408 MCD cases, and performed a comprehensive evaluation to better illustrate the causality of these variants. The results showed that majority of these variants (165 out of 181) could be classified as pathogenic or likely pathogenic. Interestingly, we also identified several disease causal variants with ethnic specificity. In addition, the results underscored the strong correlation between mutant frequency and residue conservation in the general population (Spearman’s correlation coefficient = -0.311, P = 1.20E-05), thus providing potential candidate targets for further genetic manipulation. The current study highlighted the demand of further functional investigations to evaluate the causality of CHST6 variants, so as to promote earlier accurate diagnosis of MCD and future development of potential targets for genetic therapy. |
format | Online Article Text |
id | pubmed-6382428 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Impact Journals |
record_format | MEDLINE/PubMed |
spelling | pubmed-63824282019-02-27 A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy Zhang, Jing Wu, Dan Li, Yue Fan, Yidan Dai, Yiqin Xu, Jianjiang Aging (Albany NY) Research Paper Macular corneal dystrophy (MCD) is an autosomal recessive disease featured by bilateral progressive stromal clouding and loss of vision, consequently necessitating corneal transplantation. Variants in CHST6 gene have been recognized as the most critical genetic components in MCD. Although many CHST6 variants have been described until now, the detailed mechanisms underlying MCD are still far from understood. In this study, we integrated all the reported CHST6 variants described in 408 MCD cases, and performed a comprehensive evaluation to better illustrate the causality of these variants. The results showed that majority of these variants (165 out of 181) could be classified as pathogenic or likely pathogenic. Interestingly, we also identified several disease causal variants with ethnic specificity. In addition, the results underscored the strong correlation between mutant frequency and residue conservation in the general population (Spearman’s correlation coefficient = -0.311, P = 1.20E-05), thus providing potential candidate targets for further genetic manipulation. The current study highlighted the demand of further functional investigations to evaluate the causality of CHST6 variants, so as to promote earlier accurate diagnosis of MCD and future development of potential targets for genetic therapy. Impact Journals 2019-02-04 /pmc/articles/PMC6382428/ /pubmed/30716718 http://dx.doi.org/10.18632/aging.101807 Text en Copyright: © 2019 Zhang et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Zhang, Jing Wu, Dan Li, Yue Fan, Yidan Dai, Yiqin Xu, Jianjiang A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy |
title | A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy |
title_full | A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy |
title_fullStr | A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy |
title_full_unstemmed | A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy |
title_short | A comprehensive evaluation of 181 reported CHST6 variants in patients with macular corneal dystrophy |
title_sort | comprehensive evaluation of 181 reported chst6 variants in patients with macular corneal dystrophy |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382428/ https://www.ncbi.nlm.nih.gov/pubmed/30716718 http://dx.doi.org/10.18632/aging.101807 |
work_keys_str_mv | AT zhangjing acomprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy AT wudan acomprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy AT liyue acomprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy AT fanyidan acomprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy AT daiyiqin acomprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy AT xujianjiang acomprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy AT zhangjing comprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy AT wudan comprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy AT liyue comprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy AT fanyidan comprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy AT daiyiqin comprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy AT xujianjiang comprehensiveevaluationof181reportedchst6variantsinpatientswithmacularcornealdystrophy |